Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Progression to Impaired Glucose Metabolism in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran Publisher Pubmed



Janghorbani M1, 2 ; Amini M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Diabetes/Metabolism Research and Reviews Published:2009


Abstract

Background: The aim of this study was to estimate the progression rates from normal glucose tolerance (NGT) to impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes, and from IFG and IGT to diabetes in first-degree relatives (FDRs) of individuals with type 2 diabetes mellitus. Methods: A total of 701 non-diabetic FDRs of consecutive patients with type 2 diabetes aged 20-70 years in 2003-2005 were followed through 2007 for the occurrence of IGT, IFG and type 2 diabetes. Glucose tolerance classification was based on the criteria of the American Diabetes Association and standard 75 g 2-h oral glucose tolerance test (OGTT). Results: The progression rate from NGT to IFG, IGT and diabetes were 8.6% (95% confidence interval (CI) 6.8-10.6), 3.7% (95% CI: 2.5-5.1) and 0.5% (95% CI: 0.1-1.2) per year after an average of 27.6 months, respectively. Progression rates from IFG and IGT to diabetes were 5.1% (95% CI: 2.1-10.2) and 9.9% (95% CI: 7.7-12.6) per year. Conclusions: To our knowledge, these are the first estimate of progression rates from NGT to IFG, IGT and diabetes in FDRs of individuals with type 2 diabetes in Iran. The progression rates to diabetes in these participants are high, and intensive follow-up and intervention strategies are recommended for these high-risk individuals. Copyright © 2009 John Wiley & Sons, Ltd.
Other Related Docs
26. Risk of Diabetes in Combined Metabolic Abnormalities and Body Mass Index Categories, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2016)
37. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
45. Glycemic Control Among Iranian People With Type 2 Diabetes: A Systematic Review and Meta-Analysis, International Journal of Diabetes in Developing Countries (2023)
48. Gestational Diabetes Mellitus in Plymouth, U.K.: Prevalence, Seasonal Variation and Associated Factors, Journal of Reproductive Medicine for the Obstetrician and Gynecologist (2006)
50. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)